Details for Patent: 8,927,592
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,927,592 protect, and when does it expire?
Patent 8,927,592 protects JEVTANA KIT and is included in one NDA.
Protection for JEVTANA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-three patent family members in thirty-four countries.
Summary for Patent: 8,927,592
|Title:||Antitumoral use of cabazitaxel|
|Abstract:||The invention relates to a compound of formula: ##STR00001## which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.|
|Inventor(s):||Gupta; Sunil (Chester Springs, PA)|
|Assignee:||Aventis Pharma SA (Antony, FR)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 8,927,592|
Patent Claim Types:|
see list of patent claims
Drugs Protected by US Patent 8,927,592
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use||Submissiondate|
|Sanofi Aventis Us||JEVTANA KIT||cabazitaxel||SOLUTION;INTRAVENOUS||201023-001||Jun 17, 2010||AP||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||Y||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Patented / Exclusive Use||>Submissiondate|
International Family Members for US Patent 8,927,592
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Argentina||078824||See Plans and Pricing|
|Australia||2010310986||See Plans and Pricing|
|Australia||2015200149||See Plans and Pricing|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|